Hypothalamic–pituitary–somatotropic axis Hypothalamic–pituitary–somatotropic axis The hypothalamic–pituitary–somatotropic axis (HPS axis), or hypothalamic–pituitary–somatic axis, also known as the hypothalamic–pituitary–growth axis, is a hypothalamic–pituitary axis which includes the secretion of growth hormone (GH; somatotropin) from the somatotropes of the pituitary gland into the circulation and the subsequent stimulation of insulin-like growth factor 1 (IGF-1; somatomedin-1) production by GH in tissues such as, namely, the liver. Other hypothalamic–pituitary hormones such as growth hormone-releasing hormone (GHRH; somatocrinin), growth hormone-inhibiting hormone (GHIH; somatostatin), and ghrelin () are involved in the control of GH secretion from the pituitary gland. The HPS axis is involved in postnatal human growth. Individuals
Pituitary adenoma only, with no other associated symptoms that occur in Multiple endocrine neoplasia Type 1 or Carney complex. FIPA was first described in a limited cohort of families by group in Liège, Belgium ; later FIPA was fully characterized in a multicenter international study of 64 families. FIPA families are divided into those that are homogenous and have the same type of pituitary adenoma in all the affected family members (e.g. only acromegaly, only prolactinoma, etc) , while heterogeneous FIPA families can have different pituitary adenomas in affected family members. FIPA has two known genetic causes, mutations in the "aryl hydrocarbon